Further exploration of this topic will include multivariate survival analysis to determine if Cks1 is an independent prognostic variable and to evaluate whether Cks1 expression segregates with the presence or absence of specific gene mutations involved in melanoma such as BRAF and NRAS. The gene discussed is BRAF; the disease is melanoma.